Effective 11/01/2021 coverage of non-invasive prenatal trisomy screening using cell-free fetal DNA (deoxyribonucleic acid) has been expanded to include pregnant members age 30 and older.

This benefit also will include twin pregnancies, but not higher multi-gestational pregnancies. 

Consistent with current policy, non-invasive prenatal trisomy screening will continue to be covered when at least one of the following criteria is met:

• Either parent has a family history of aneuploidy in a first* or second** degree relative.
• Standard serum screening or fetal ultrasonographic findings indicate an increased risk of aneuploidy.
• Parent(s) have a history of a previous pregnancy with a trisomy.
• Either parent is known to have a Robertsonian translocation.

Definitions:

^*First degree relatives: Parents, children, siblings
^** Second degree relatives: Grandparents, aunts and uncles, nieces and nephews, and grandchildren

Note: This is an update to the October 2014 Medicaid Update article titled NYS Medicaid Now Covers Non-invasive Prenatal Testing for Trisomy 21, 18 and 13.

You can find the updated version of this policy (NY Medicaid) here.  

Recent Blog Posts:

• FidelisCare: pre- pay claim review for COB – third party payers
• Tobacco screening services- proper coding and billing- UPMC Community Behavioral Health Org:UPMC Community Behavioral Health Org
• Are you using the proper Anesthesia codes for fascial plane blocks?
• HighMark BCBS: reimbursement for massage therapy services
• NYS Medicaid: reduce denials MAT/ OASAS services-